Ingredient or product comparison
Regulatory Classification: Cosmetic vs Research-Grade Peptides
Cosmetic GHK-Cu falls under FDA cosmetic regulations, which require safety but impose no obligation to prove efficacy or disclose exact peptide concentration. Manufacturers can list 'copper peptides' or 'palmitoyl tripeptide-1 copper complex' on an INCI label
This source-based comparison does not add ratings or recommend a winner.
- Cosmetic GHK-Cu falls under FDA cosmetic regulations, which require safety but impose no obligation to prove efficacy or disclose exact peptide concentration. Manufacturers can list 'copper peptides' or 'palmitoyl tripeptide-1 copper complex' on an INCI label without specifying whether the product contains 0.01% or 1% bioavailable GHK-Cu. The regulatory ceiling for cosmetic claims is appearance-based only. 'reduces the appearance of fine lines,' 'supports skin texture'. Any claim suggesting a biological mechanism (stimulates collagen, inhibits matrix metalloproteinases) reclassifies the product as a drug under 21 CFR 310, triggering requirements for clinical trial data and pre-market approval.
- Research-grade topical GHK-Cu is synthesised by facilities operating under cGMP (current Good Manufacturing Practice) or ISO 17025 laboratory standards, producing peptides at ≥98% purity verified by HPLC and mass spectrometry. These peptides are sold 'for research use only'. Not for human consumption or cosmetic application. And are exempt from cosmetic labeling requirements because they're classified as laboratory reagents, not consumer products. The distinction isn't semantic: a 5mg vial of research-grade GHK-Cu from Real Peptides undergoes amino-acid sequencing verification; a cosmetic serum listing copper peptides as the seventh ingredient on a label does not.
- The practical implication: if you're sourcing peptides for cellular assays, collagen expression studies, or fibroblast activity experiments, cosmetic-grade products are categorically unsuitable. The peptide content is unverified, the carrier base introduces contamination variables, and the formulation includes preservatives and stabilisers that interfere with in-vitro protocols. Research peptides are lyophilised (freeze-dried) powders reconstituted in bacteriostatic water or specified solvents at known concentrations. Cosmetic serums are pre-mixed emulsions where the active peptide represents a fraction of total product weight.